Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$156,054,661
+$61,552,604 QoQ
Shares Held
1,235,196
+82.2% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#104
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 56%
Shared 0%
None 44%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Mar 31, 2022CallValue
$422,095
CallShares
7,100
PutValue
$422,095
PutShares
7,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Man Group plc holds $1,927,079,072 across 11 Drug Manufacturers - General names. GILD ranks #4 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
398,861 | $478,405,888 | |
| 2 | ABBV |
AbbVie Inc.
|
1,704,016 | $428,798,585 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
4,682,000 | $269,776,838 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
1,235,196 | $156,054,661 | |
| 5 | JNJ |
Johnson & Johnson
|
517,830 | $131,513,284 | |
| 6 | AZN |
Astrazeneca PLC
|
683,112 | $129,531,696 | |
| 7 | MRK |
Merck & Co., Inc.
|
990,469 | $127,275,266 | |
| 8 | AMGN |
Amgen Inc
|
234,023 | $84,744,407 |
All Filings in GILD
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $156,054,661 | 1,235,196 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $94,502,057 | 678,066 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $211,740,245 | 1,725,112 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $194,981,601 | 1,756,591 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $174,615,259 | 1,574,955 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $186,517,084 | 1,664,588 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $80,655,542 | 873,179 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $52,786,669 | 629,612 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $81,624,698 | 1,189,691 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $72,614,482 | 991,324 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $37,211,861 | 459,349 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $42,902,999 | 572,498 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $85,438,028 | 1,108,577 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $122,968,508 | 1,482,084 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $197,359,704 | 2,298,890 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $102,091,025 | 1,654,904 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $89,670,423 | 1,450,743 | Principal | Defined | 2022-08-15 | |
| 2022-03-31 | $59,303,157 | 997,530 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $422,095 | 7,100 | Call | Defined | 2022-05-16 | |
| 2022-03-31 | $422,095 | 7,100 | Put | Defined | 2022-05-16 | |
| 2021-12-31 | $48,041,316 | 661,635 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $26,768,475 | 383,228 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $36,802,708 | 534,457 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $80,942,481 | 1,252,398 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $71,211,837 | 1,222,311 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $76,745,328 | 1,214,517 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $79,840,637 | 1,037,700 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $43,153,415 | 577,226 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||